SEARCH

SEARCH BY CITATION

References

  • 1
    Stapleton J. A., Watson L., Spirling L. I., Smith R., Milbrandt A., Ratcliffe M. et al. Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2008; 103: 14654.
  • 2
    Russell M. A. H. Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. In: PomerleauO. F., PomerleauC. S., editors. Nicotine Replacement: A Critical Evaluation. New York: Alan R. Liss, Inc.; 1988, p. 6394.
  • 3
    Moore D., Wang D., Connock M., Barton P., Fry-Smith A., Aveyard P. Cut down to quit with nicotine replacement therapies in smoking cessation: systematic review of effectiveness and economic analysis. NHS R&D HTA Programme. National Institute for Health and Clinical Excellence; 2007. Available at: http://www.nice.org.uk/nicemedia/pdf/SmokingCessationEconomicAnalysisCDTQwithNRT.pdf (accessed February 2007).
  • 4
    Shiffman S., Ferguson S. G. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 2008; 103: 55763.
  • 5
    Kozlowski L. T., Porter C. Q., Orleans C. T., Pope M. A., Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HIS. Drug Alcohol Depend 1994; 34: 2116.
  • 6
    Johnston L. M. Tobacco smoking and nicotine. Lancet 1942; 243: 742.
  • 7
    Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; Issue 3. Art. No.: CD000146. DOI: 10.1002/14651858.CD000146.pub2 (accessed 12 November 2007).
  • 8
    Schuurmans M. M., Diacon A. H., Van Biljon X., Bolliger C. T. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Addiction 2004; 99: 63440.